Anti-CEACAM1 antibody

Cat.#: 141212

Special Price 161.3 USD

Availability:
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-CEACAM1 antibody
  • Documents
  • Description
    Mouse Monoclonal to Rat CEACAM1
  • Tested applications
    FCM
  • Species reactivity
    Rat CEACAM‑1/CD66a
  • Alternative names
    bb-1 antibody; Bgp antibody; BGP antibody; BGP1 antibody; Bgp1 antibody; BGPI antibody; Cc1 antibody; C-CAM antibody; CD66a antibody; CD66a antibody; Cea1 antibody; Cea-1 antibody; Cea7 antibody; Cea-7 antibody; Ceacam1 antibody; CEACAM1 antibody; Hv2 antibody; Hv-2 antibody; mCEA1 antibody; Mhv-1 antibody; MHVR antibody; MHVR1 antibody; mmCGM1 antibody; mmCGM1a antibody; mmCGM2 antibody; CEACAM‑1 antibody; CC1 antibody; BGP antibody; BGP1 antibody; BGPI antibody; Bgp antibody; Hv2 antibody; Bgp1 antibody; Cea1 antibody; Cea7 antibody; Hv-2 antibody; MHVR antibody; bb-1 antibody; C-CAM antibody; CD66a antibody; Cea-1 antibody; Cea-7 antibody; MHVR1 antibody; Mhv-1 antibody; mCEA1 antibody; mmCGM1 antibody; mmCGM2 antibody; mmCGM1a antibody
  • Immunogen
  • Isotype
    Mouse IgG1
  • Preparation
    This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Rat CEACAM‑1/CD66a and conjugated with PE under optimum conditions, the unreacted PE was removed.
  • Clonality
    Monoclonal
  • Formulation
    Aqueous solution containing 0.5% BSA and 0.09% sodium azide
  • Storage instructions
    This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !
    Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
  • Applications
    FCM
  • Validations

    Rat CEACAM‑1/CD66a Flow Cytometry (FC) 15888

    Rat CEACAM‑1/CD66a Flow Cytometry (FC) 15888

  • Background
    The carcinoembryonic-antigen-related cell-adhesion molecule (CEACAM) family of proteins has been implicated in various intercellular-adhesion and intracellular-signalling-mediated effects that govern the growth and differentiation of normal and cancerous cells. CEACAM1, also known as biliary glycoprotein I (BGP I) and CD66a, is a member of the carcinoembryonic antigen (CEA) gene family which belongs to the immunoglobulin superfamily. The highly glycosylated CEACAM1 contains one N-terminal V-type Ig-like domain and three C2-type Ig-like domains within its ECD, and one ITIM motif and a calmodulin binding site in the cytoplasmic region. CEACAM1 is a surface glycoprotein expressed on various blood cells, epithelial cells, and vascular cells. It was described as an adhesion molecule mediating cell adhesion via both homophilic and heterophilic manners, and was detected on leukocytes, epithelia, and endothelia. Studies have revealed that CEACAM1 performs actions in multiple cellular processes including tissue differentiation, angiogenesis, apoptosis, metastasis, as well as the modulation of innate and adaptive immune responses.

    Immune Checkpoint
    Immune Checkpoint Detection: ELISA Antibodies   Immune Checkpoint Detection: IHC Antibodies   Immune Checkpoint Detection: ICC Antibodies   Immune Checkpoint Detection: FCM Antibodies   Immune Checkpoint Detection: WB Antibodies
    Immune Checkpoint Proteins
    Immune Checkpoint Targets   Co-inhibitory Immune Checkpoint Targets

    Immunotherapy   Cancer Immunotherapy   Targeted Therapy

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"